394-69-4 Usage
General Description
5-Fluoro Quinoline is a chemical compound that consists of a quinoline ring with a fluorine atom at the 5-position. It is a heterocyclic aromatic compound with potential applications in pharmaceutical and chemical research. 5-Fluoro Quinoline has been studied for its potential use as an antimalarial drug due to its ability to inhibit the growth of malarial parasites. Additionally, it has demonstrated antimicrobial and antifungal properties, making it a potential candidate for the development of new antibiotics. Its chemical structure and properties make it a useful building block for the synthesis of various pharmacologically active compounds. However, further research is needed to fully understand its potential applications and effects.
Check Digit Verification of cas no
The CAS Registry Mumber 394-69-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,9 and 4 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 394-69:
(5*3)+(4*9)+(3*4)+(2*6)+(1*9)=84
84 % 10 = 4
So 394-69-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H6FN/c10-8-4-1-5-9-7(8)3-2-6-11-9/h1-6H
394-69-4Relevant articles and documents
7-Dialkylamino-1-alkylquinolinium salts: Highly versatile and stable fluorescent probes
Van Den Berg, Otto,Jager, Wolter F.,Picken, Stephen J.
, p. 2666 - 2676 (2006)
7-Dialkylamino- and 7-alkylsulfenyl-1-alkylquinolinium salts have been synthesized using a novel synthetic approach. The key intermediate, 7-fluoro-1-methylquinolinium iodide, was shown to possess high reactivity toward nitrogen and sulfur nucleophiles, a
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
Page/Page column 179, (2014/09/29)
Compounds of general formula (I) and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
Page/Page column 192; 193, (2014/09/29)
Compounds of general formula (I) and compositions comprising compounds of general formula (I) that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.